Exchange: OTC·Updated 03:59 PM EDT

RDGL Vivos Inc

$0.0533
$0.0024
(4.71%)
Today
Mkt Cap$26.34M
Vol500,661.00

About RDGL

Vivos, Inc. is a radiation oncology medical device company. It is engaged in the development of its yttrium-90 based brachytherapy device, RadioGel, for the treatment of non-resectable tumors. Its product, RadioGel, is an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals. The company was founded by James C. Katzaroff on December 23, 1994 and is headquartered in Kennewick, WA.
35

Bearish Sentiment

How do you feel about RDGL?

Advertisement|Remove ads.